Searle Celebrex Alzheimer's Trial To Finish By End Of January In U.K.

A pilot study of Searle's nonsteroidal anti-inflammatory drug Celebrex (celecoxib) for Alzheimer's is slated to finish by the end of January, according to data in the U.K. Department of Health's National Research Register database.